Home Drug Codes J Codes J8501 · APREPITANT
Updated July 1st, 2026

APREPITANT J Code: J8501

Aprepitant, oral, 5 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J8501, effective October 1, 2026: $2.511 per HCPCS billing unit, down 18.2% from $3.069. From CMS's final file.

?
Medicare Payment Limit ?
$3.069
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
33
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Aprepitant, oral, 5 mg
HCPCS Added Date January 1, 2005
Manufacturer Multiple Manufacturers
Route of Administration Oral
Generic Status Multi-Source; Generic
Dosage Form Capsule | Kit | Powder, For Suspension

About APREPITANT

Aprepitant is a medication aligned to the HCPCS J Code: J8501 for billing, pricing, and reimbursement purposes in the United States. Classified under Anti-Emetic, it is administered via the oral route and manufactured by multiple companies.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 33 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00006-0461-02 Emend Merck Sharp & Dohme LLC 32 80 MG
00781-2321-06 Aprepitant Sandoz Inc 8 40 MG
13668-0591-81 Aprepitant Torrent Pharmaceuticals Limited 8 40 MG
68001-0666-01 Aprepitant BluePoint Laboratories 8 40 MG
68462-0112-33 Aprepitant Glenmark Pharmaceuticals Inc., USA 57 Kit
•••••-••••-•• Log in to view APREPITANT
APREPITANT
APREPITANT
Login to view 28 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

APREPITANT Pricing & Reimbursement

J8501 Private Payer Reimbursement
$2.68 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

APREPITANT CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96375 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug.
96367 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Aprepitant (J8501) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J8501. Wastage billing guide →

APREPITANT Medically Unlikely Edits (MUE)

The most billing units of J8501 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 5 mg. The limit is different in the office and the hospital. Use the one for your setting.

Practitioner Office
0 units / day
Not payable in this setting
Hospital Outpatient
57 units / day
= 285 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

APREPITANT Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Chemotherapy Induced Nausea and Vomiting Chemotherapy Induced Nausea and Vomiting (CINV) Postoperative Nausea and Vomiting Postoperative Nausea and Vomiting (PONV) nausea and vomiting associated with highly emetogenic cancer chemotherapy (HEC) nausea and vomiting associated with moderately emetogenic cancer chemotherapy (MEC)
Drug Class
Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A4 Inducers [MoA]Cytochrome P450 3A4 Inhibitors [MoA]Neurokinin 1 Antagonists [MoA]Substance P/Neurokinin-1 Receptor Antagonist [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Aprepitant billing and coding guide?
We have not yet identified a manufacturer source of Aprepitant billing and coding information.
Are there any available Aprepitant patient assistance programs?
Our team did not identify a source for Aprepitant patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Aprepitant prescribing information?
APREPITANT prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →
Where can I find Aprepitant side effect information?
Our team has not yet identified a source of side effects information for APREPITANT. Please check back in a few weeks.
Does billing APREPITANT require JZ/JW wastage modifiers?
CMS does not include APREPITANT (J8501) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J8501. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.